Pioneering the development of advanced breast-imaging technologiesGE Healthcare has been a leader in the field of breast cancer detection through mammography devices since the 1960s. GE Healthcare estimates that since then, it is more than 20 billion women who have benefited from its diagnostic imaging technologies worldwide. In 1999, GE Healthcare was the first company to introduce full-field digital mammography (FFDM). The company has spent 13 years and more than $100 million developing the full-field digital mammography technology, GE Healthcare Senographe?® systems, and continues to invest heavily in new cutting-edge technologies to detect the pathology before the onset.

The company has spent 13 years and more than $100 million developing the full-field digital mammography technology, GE Healthcare Senographe?® systems, and continues to invest heavily in new cutting-edge technogies to detect the pathology before the onset.

Today there are approximately 3800 GE Healthcare Senographe?® digital systems in use worldwide -- more than any other brand. In August this year, healthcare technology research organization KLAS ranked GE Healthcares Senographe DS as the best digital mammography system on the market today, based on a survey of healthcare providers.

Through its own research as well as partnerships with other industry innovators, GE Healthcare is continuing to bring to market advanced technologies that will help improve detection and reduce unnecessary biopsies in the future, including a magnetic resonance imaging (MRI) system specifically designed for breast imaging; the fusion of FFDM and ultrasound; and tomosynthesis -currently under clinical investigation- which generates three-dimensional images.

www.gehealthcare